GERD—Barrett—Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?

Figure 1

GERD-associated progression for Barrett’s esophagus (BE) to esophageal adenocarcinoma (EAC). A–D refer to biomarkers which could be most relevant at the indicated stages of the disease progression (according to Table 1). Therefore A, B, C, and D stand for diagnostic, progressive, predictive, and prognostic biomarkers, respectively.